# Xilio Therapeutics, Inc.: Form 8-K, filed Oct 3, 2025

- Company: [Xilio Therapeutics, Inc.](/companies/xlo.md) (CIK 1840233)
- Form: 8-K
- Filed: 2025-10-03
- Accepted by EDGAR: Oct 3, 2025, 07:30 ET
- Period: 2025-10-02
- Accession: 0001193125-25-229231
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1840233/000119312525229231/d74952d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1840233/000119312525229231/

## Items reported

- Item 3.01: Delisting notice

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1840233/000119312525229231/d74952d8k.htm

Filed Oct 3, 2025.
Source: SEC EDGAR, the filing index for accession 0001193125-25-229231. Last ingested by Listed: Nov 15, 2026, 04:19 ET. No prices; not investment advice.
